The ethics of type 1 diabetes prediction and prevention research

Lainie Friedman Ross1

  • 1Department of Pediatrics, University of Chicago, IL 60637, USA. lross@uchicago.edu

Insights

Type 1 diabetes (T1D) research must ethically involve children. This study reviews current methodologies against federal regulations and proposes policy changes to ensure ethical child T1D research practices for better prediction and prevention.

Area of Science:

  • Pediatric Endocrinology
  • Clinical Research Ethics
  • Public Health Policy

Background:

  • Type 1 diabetes (T1D) affects approximately one million individuals in the US, with a rising global incidence.
  • Two-thirds of T1D cases are diagnosed in childhood, highlighting the critical need for pediatric research.
  • Existing ethical guidelines for human subject research are established by the National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research.

Purpose of the Study:

  • To evaluate current T1D research methodologies for ethical compliance concerning child participants.
  • To assess adherence to federal regulations protecting human research subjects.
  • To propose policy recommendations for ethical pediatric T1D study design.

Main Methods:

  • Review of existing T1D research studies involving children.
  • Analysis of research methodologies against established ethical guidelines and federal regulations.
  • Development of policy recommendations based on ethical principles.

Main Results:

  • Current research methodologies may not fully align with ethical requirements for pediatric T1D research.
  • Gaps exist in ensuring comprehensive protection for child subjects in T1D studies.
  • The study identifies areas for improvement in ethical research conduct.

Conclusions:

  • Ethical considerations are paramount in pediatric T1D research for accurate prediction and prevention.
  • Policy adjustments are necessary to strengthen ethical oversight in child-focused T1D studies.
  • Adherence to ethical guidelines ensures the protection and well-being of children participating in research.

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.